Connection

Graham Warren to Disease-Free Survival

Back to Details
This is a "connection" page, showing publications Graham Warren has written about Disease-Free Survival.
Graham Warren
Connection Strength
0.112
Disease-Free Survival
  1. A phase II trial of erlotinib monotherapy in advanced pancreatic cancer as a first- or second-line agent. Cancer Chemother Pharmacol. 2017 Sep; 80(3):497-505.
    View in: PubMed
    Score: 0.033
  2. The Effects of smoking status and smoking history on patients with brain metastases from lung cancer. Cancer Med. 2017 May; 6(5):944-952.
    View in: PubMed
    Score: 0.032
  3. Survival rates and prognostic factors for infiltrating salivary duct carcinoma: Analysis of 228 cases from the Surveillance, Epidemiology, and End Results database. Head Neck. 2014 May; 36(5):694-701.
    View in: PubMed
    Score: 0.025
  4. Pretreatment nutritional status and locoregional failure of patients with head and neck cancer undergoing definitive concurrent chemoradiation therapy. Head Neck. 2011 Nov; 33(11):1561-8.
    View in: PubMed
    Score: 0.021
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.